Yide Alan Jiang
Direktor/Vorstandsmitglied bei QuantumPharm, Inc.
Vermögen: 7 Mio $ am 31.05.2024
Profil
Yide Alan Jiang is currently the Executive Director & Chief Strategic Officer at QuantumPharm, Inc. He holds a doctorate degree from the University of Tennessee, which he obtained in 1999.
He also has an undergraduate degree from Shanghai Medical College of Fudan University, which he received in 1987.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
QuantumPharm, Inc.
QuantumPharm, Inc. BiotechnologyHealth Technology QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. 0,29% | 13.06.2024 | 10 000 000 ( 0,29% ) | 7 Mio $ | 31.05.2024 |
Aktive Positionen von Yide Alan Jiang
Unternehmen | Position | Beginn |
---|---|---|
QuantumPharm, Inc.
QuantumPharm, Inc. BiotechnologyHealth Technology QuantumPharm, Inc. operates as a holding company with interests in drug research and development services. It engages in the business relating to drug discovery solutions including one-stop drug discovery solutions and automated chemical synthesis services and intelligent automation services. The company was founded by Lai Li Ppeng, Ma Jian and Wen Shu Hao in 2015 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | 17.11.2017 |
Ausbildung von Yide Alan Jiang
Shanghai Medical College of Fudan University | Undergraduate Degree |
University of Tennessee | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
Health Technology |